Drug Shortage Report for TEVA-OMEPRAZOLE
| Report ID | 237473 |
| Drug Identification Number | 02295415 |
| Brand name | TEVA-OMEPRAZOLE |
| Common or Proper name | OMEPRAZOLE 20MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-10 |
| Estimated end date | 2025-11-10 |
| Actual end date | 2025-11-10 |
| Shortage status | Resolved |
| Updated date | 2025-12-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v38 | 2025-06-05 | French | Compare |
| v37 | 2025-06-05 | English | Compare |
| v36 | 2025-05-30 | French | Compare |
| v35 | 2025-05-30 | English | Compare |
| v34 | 2025-05-15 | French | Compare |
| v33 | 2025-05-15 | English | Compare |
| v32 | 2025-05-02 | French | Compare |
| v31 | 2025-05-02 | English | Compare |
| v30 | 2025-04-24 | French | Compare |
| v29 | 2025-04-24 | English | Compare |
| v28 | 2025-04-10 | French | Compare |
| v27 | 2025-04-10 | English | Compare |
| v26 | 2025-04-04 | French | Compare |
| v25 | 2025-04-04 | English | Compare |
| v24 | 2025-03-27 | French | Compare |
| v23 | 2025-03-27 | English | Compare |
| v22 | 2025-03-20 | French | Compare |
| v21 | 2025-03-20 | English | Compare |
| v20 | 2025-03-13 | English | Compare |
| v19 | 2025-03-13 | French | Compare |